The results of this week’s poll about Medicare cap extension.
The results are in and 75% of our readers think the Medicare $2,000 per-year cap on out-of-pocket costs for prescription drugs should not be extended to commercial insurance.
A $3,250 cap went into effect this year and will be lowered to $2,000 next year. At this time, it only applies to Medicare enrollees with Part D coverage.
We want to know what you’re thinking! Every Monday morning, the editors of Managed Healthcare Executive are posing a question to our readers about a timely issue in U.S. healthcare. We collect your answer and post the results on Friday.
DC Roundtable: Patrick Cooney of The Federal Group Drops the Latest on PBM Legislation in Washington
April 11th 2024In this episode of "DC Roundtable," Peter Wehrwein, managing editor of Managed Healthcare Executive, spoke with Patrick Cooney, president of The Federal Group, a lobbying and strategic planning firm in Washington, D.C., about recent developments in Washington concerning PBMs.
Listen